Clinical Trial Update: Sarcomas and DDR-Inhibition; a Combined Modality Study [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating DDR inhibition in soft tissue sarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Soft Tissue Sarcoma Adult | Phase 1 | Status: TERMINATED